Rajin Ahuja


Mr. Ahuja possesses over 15 years of global experience in pharmaceutical mergers and acquisitions (M&A), and has an extensive background in drug development and codevelopment partnerships. He has enjoyed a long and successful career in the pharmaceutical industry, having played key roles that ranged from the creation of new companies to licensing intellectual property (IP) to serving at several major drug companies worldwide.

Mr. Ahuja founded and launched his first pharmaceutical company while in his mid twenties, a company which successfully achieved FDA approval on three first to market drugs. He has had direct involvement in the interaction, negotiation, and licensing of many drugs with some of the most preeminent pharmaceutical companies in the world. His experience as an entrepreneur has led to the successful creation of several startup pharmaceutical companies that resulted in multimillion dollar valuations. In these ventures, he has been involved in raising the necessary capital to develop + commercialize products, and his expertise and experience have been instrumental in extracting top value for development funds.  Recently, he has globalized his pharmaceutical reach into India, Russia, Canada, and South America.

Mr. Ahuja is also a managing partner for an investment firm that deals in medically related investments. The projects in process range from $1 million to more than $100 million within the health care sector. He currently holds board seats in several companies and provides strategic advice for many startups and medical companies.

Mr. Ahuja received a Bachelor of Science degree in biology with a premed emphasis from Gannon University/ Hahnemann Medical and earned an MBA at Pennsylvania as well.